Should there be an accredited ethics committee system for centralised review of multicentre clinical research?

被引:12
作者
Beran, RG [1 ]
机构
[1] Liverpool Hosp, Liverpool, NSW, Australia
关键词
D O I
10.5694/j.1326-5377.1998.tb126774.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Australia's current decentralised system of institutional ethics committees has disadvantages for multicentre trials and for private clinicians who wish to undertake research. This article proposes a potential remedy for this situation.
引用
收藏
页码:174 / 176
页数:3
相关论文
共 8 条
  • [1] *AGPS, 1996, REP REV ROL FUNCT I
  • [2] *APMA, 1994, FORM IND CLIN TRIALS
  • [3] *APMA, 1994, GUID COMP INJ RES PA
  • [4] Baume P, 1991, QUESTION BALANCE REP
  • [5] CLINICAL-TRIALS OF ANTIEPILEPTIC DRUGS PERFORMED IN THE PRIVATE-PRACTICE SETTING
    BERAN, RG
    TILLEY, M
    [J]. EPILEPSIA, 1994, 35 (01) : 101 - 106
  • [6] *NAT HLTH MRC, 1995, AUSTR HLTH ETH COMM
  • [7] Stone PG, 1997, BRIT MED J, V315, P60
  • [8] *SUNDH, 1997, BEK AF LOV VID KOM B, V1068